Women on Web, a Canadian pro-abortion group that operates out of the Netherlands, is working hard to make available dangerous abortion-inducing to pregnant women in South America infected with the Zika virus. Although not typically deadly, the virus has been linked to birth defects in children born to infected women. The mosquito-borne virus is considered the culprit in the rise of microcephaly-afflicted babies born throughout South America over the last year. Microcephaly is a neurological disorder that usually manifests itself in the form of babies born with abnormally small heads and associated brain damage.
Although abortion is generally illegal throughout South America, that has not stopped the diligent folks at Women on Web from trying to get abortion medications to women fearful of the prospect of giving birth to babies with birth defects. In order to be mailed a package of abortion drugs from Women on Web, an interested recipient must complete an online consultation form. Once completed, the group mails out packages of misoprostol and mifepristone, which can be used to cause abortions.
For its part, Brazilian authorities have been very aggressive in intercepting and otherwise confiscating the packages sent by the group. According to Women on Web, 95 percent of the packages they’ve sent to women in that country have been seized by authorities.
Besides the obvious fact that the group is aggressively encouraging abortions, there are other, troubling issues, as well. For one thing, birth defects like microcephaly cannot be diagnosed until a pregnancy reaches at least 20 weeks, while the abortion drugs can be used no later than nine weeks. This means that infected women could well be aborting perfectly healthy unborn babies. Another problem is that the abortion drugs are not meant to be used by a woman without supervision. They are actually very dangerous drugs that have been responsible for numerous deaths (and that is, of course, aside from the unborn babies) and thousands of injuries over the last 12 months, according to the Food and Drug Administration.
By Robert G. Yetman, Jr. Editor At Large